Birmingham, 18 September 2024 – Roseway Labs has been named Pharma Company of the Year – SME at the Pharma Industry Awards UK 2024.
The awards ceremony, which took place at the International Convention Centre (ICC) in Birmingham, celebrates the exceptional achievements, innovations, and leadership across the UK’s pharmaceutical industry.
The Pharma Industry Awards, renowned for highlighting the most influential and pioneering companies in the sector, featured 21 categories and 73 finalists, showcasing contributions across innovation, research and development, partnerships, women in pharma and more.
Winning this prestigious award celebrates our commitment to innovation, patient care, and excellence in the pharmaceutical industry.
Roseway Labs CEO and Cofounder, Elizabeth Philp, said:
“This award is a testament to all the people in Roseway Labs, who work tirelessly to help our patients and prescribers each and every day. Whilst I had the privilege of collecting the award, it is the collective effort that got us here. An amazing result of which we can all be proud”.
Founded in 2018 with a vision to increase access to personalised medicine, we have continued to push the boundaries in compounding medications, delivering tailored treatments to meet patients’ individual needs.
Our success in the past 12 months, particularly in maintaining a stable supply of compounded progesterone during the national Utrogestan shortage in 2023, demonstrates our unwavering focus on quality, safety, and patient outcomes.
The judges also commended our ability to navigate external challenges and deliver effective solutions in times of crisis:
“Roseway Labs responded well to external challenges and found original solutions for customers in crisis situations – truly demonstrating all the qualities of a victor.”
